AI assistant
Coloplast — Board/Management Information 2018
Nov 12, 2018
3358_rns_2018-11-12_1d61b5f2-b78a-4fe2-bf51-92909b1abc90.pdf
Board/Management Information
Open in viewerOpens in your device viewer
C
C
C
C
C
C
C
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
Ostomy Care
Continence Care
Wound & Skin Care
Urology Care
NASDAQ Copenhagen
12 November 2018
Coloplast A/S
Holtedam 1
3050 Humlebæk
Denmark
Tlf: +45 4911 1111
www.coloplast.com
CVR-nr. 69749917
Announcement no. 11/2018
Paul Marcun to join Coloplast A/S Executive Management as Executive Vice President, Chronic Care
Today, Coloplast announces that Paul Marcun will join Coloplast's Executive Management as Executive Vice President, Chronic Care in mid-January 2019. Paul takes over from Kristian Villumsen who will as of December 4th assume the role as President and CEO of Coloplast. As Executive Vice President, Chronic Care Paul will be responsible for Global Marketing, the sales regions and the innovation pipeline within Ostomy Care and Continence Care.
Following Paul's appointment, Coloplast's Executive Management will as of mid-January consist of four members, Kristian Villumsen, President & CEO, Anders Lonning-Skovgaard, EVP & CFO, Allan Rasmussen, EVP Global Operations and Paul Marcun, EVP Chronic Care.
About Paul Marcun
Paul Marcun has around 20 years' experience in the medtech industry. Paul first joined Coloplast in 2015 and has been part of Coloplast A/S' management team for more than 3 years as Senior Vice President, Emerging Markets. Prior to joining Coloplast A/S, Paul served as President Eastern Europe, Middle East, Africa & India at Stryker International and Vice President Ortho-Clinical Diagnostics and Vice President Ethicon Endo Surgery & Advanced Sterilization Products for Johnson & Johnson. Paul Marcun recently served as President of Surgical Workflows at Getinge.
Paul holds a Bachelor of Veterinary Science (Hons.) from the University of Melbourne and a Master of Business Administration from the University of Technology in Sydney. Paul is an Australian and British citizen and was born in 1966.
Kind regards,
Coloplast A/S
Lars Rasmussen, President & CEO
Coloplast
Ostomy Care
Continence Care
Wound & Skin Care
Urology Care
For more information, please contact:
Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111
Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 / 4911 3376
E-mail [email protected]
Rasmus Sørensen
Senior Manager, Investor Relations
Tel. +45 4911 1800 / 4911 1786
E-mail [email protected]
Press and the media
Lina Danstrup
Senior Media Relations Manager, Corporate Communications
Tel. +45 4911 2607
E-mail [email protected]
Website
www.coloplast.com
Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebæk
Denmark
Business reg. (CVR) no. 69749917
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2018-11 All rights reserved. Coloplast A/S, 3050 Humlebæk, Denmark.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.
Our business includes Ostomy Care, Interventional Urology, Continence Care and Wound and Skin Care. We operate globally and employ about 12,000 people.
2/2